Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Asset Writedowns and Impairment (2015 - 2024)

Updated

Theravance Biopharma (TBPH) recorded Asset Writedowns and Impairment of $4.51 million in FY2024.

Analysis

Theravance Biopharma (TBPH) Asset Writedowns and Impairment (2015 - 2024) Analysis & Trends

Starting with FY2014, Theravance Biopharma's Asset Writedowns and Impairment history includes 5 years.

  • The FY2024 figure is the highest annual Asset Writedowns and Impairment in data going back to FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 1.56 Mn
Dec 31, 2017 97,000.00
Sep 30, 2017 8.00 Mn
Jun 30, 2017 642,000.00
Dec 31, 2016 184,000.00
Jun 30, 2016 109,000.00
Mar 31, 2016 10,000.00
Dec 31, 2015 2.02 Mn
Mar 31, 2015 79,000.00
API Access

Theravance Biopharma Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=TBPH&period=max&api_key=YOUR_API_KEY